yourstate.us
Conn. Gen. Stat. § 21a-70h

Registration as pharmaceutical marketing firm. Definitions

Connecticut · General Statutes of Connecticut Chapter 417 — General Provisions. Pure Food and Drugs · Status: effective

Get this as JSONEmbed this
Cite this
Citation
Conn. Gen. Stat. § 21a-70h, Registration as pharmaceutical marketing firm. Definitions, Connecticut, version 1 as recorded 2026-10-03, yourstate.us, https://yourstate.us/provision/2190668
Permanent ID
ys:prov:2190668@1
SHA-256
9bfcf5816e7366bbce6878dcb6645ca9998823ce9cf93d602d6ff0c617f0f233

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

For the purposes of this section and sections 21a-70i to 21a-70k: (1) “Commissioner” means the Commissioner of Consumer Protection or the commissioner's authorized representative; (2) “Contact” means any communication transmitted in person or by telephone, electronic mail, text message or other electronic means between a pharmaceutical representative and a prescribing practitioner or pharmacist, to promote or provide information relating to a legend drug; (3) “Department” means the Department of Consumer Protection; (4) “Legend drug” has the same meaning as provided in section 20-571; (5) “Pharmaceutical manufacturer” (A) means a (i) person, whether within or without the boundaries of the state of Connecticut, that (I) produces, prepares, cultivates, grows, propagates, compounds, converts or processes a drug, directly or indirectly, by extraction from substances of natural origin, by means of chemical synthesis or by a combination of extraction and chemical synthesis, or (II) packages, repackages, labels or relabels a drug container under such manufacturer's own trademark or label, or any other trademark or label, for the purpose of selling the drug, or (ii) sterile compounding pharmacy, as defined in section 20-633b that dispenses sterile pharmaceuticals without a prescription or a patient-specific medical order intended for use in humans, and (B) includes, but is not limited to, a virtual manufacturer, as defined in section 20-571; (6) “Pharmaceutical marketing firm” means a pharmaceutical manufacturer that employs or compensates pharmaceutical representatives; (7) “Pharmaceutical representative” means any person, including, but not limited to, a sales representative, who markets, promotes or provides information regarding a legend drug for human use to a prescribing practitioner and is employed or compensated by a pharmaceutical manufacturer; (8) “Pharmacist” has the same meaning as provided in section 20-571; and (9) “Prescribing practitioner” has the same meaning as provided in section 20-571.